Researchers Label Early CAR-T Therapy Patient ‘Cured’ After Living a Decade Without Cancer In 2010, Doug Olson became the second person in the world to receive CAR-T cell therapy, an experimental tactic to engineer his own immune cells to fight cancer. His doctors had tempered expectations for how well it
Biden Relaunches 'Cancer Moonshot' Initiative Aimed at Halving Rate of Cancer Deaths by 2047 President Joe Biden on Wednesday relaunched the White House's "Cancer Moonshot" initiative, committing the nation to working toward reducing the death rate from cancer by at least 50% over the next 25 years. Read more...
Improving Drug Options for Colorectal Cancer Patients Patients with colorectal cancer were among the first to receive targeted therapies. These drugs aim to block the cancer-causing proteins that trigger out-of-control cell growth while sparing healthy tissues. But some patients are not eligible for these treatments because they have cancer-promoting mutations
Antipsychotic Drugs May Increase Risk of Breast Cancer Tracking medications provided to over a half million U.S. women, researchers at Washington University School of Medicine in St. Louis have found that many commonly prescribed older antipsychotic medications, and some newer ones, are associated with a significant increase in risk of
Cancer Moonshot Grant Funds Research Into Reducing Health Disparities Washington University School of Medicine in St. Louis has received a $17 million grant from the National Institutes of Health (NIH) to address disparities in cancer research, treatment and outcomes in underrepresented populations. The research, funded through the National Cancer Institute’s
Turning CAR-T Tech Against Solid Tumors by Targeting Protein Fragments in Cancer Cells CAR-T therapies, which arm a patient’s own immune cells with cancer-fighting proteins, are currently used to treat some patients with blood cancers. But the technology has been hard to apply to other cancers, partly because of a
Uncovering How Injury to the Pancreas Impacts Cancer Formation Scientists at the Salk Institute and Vanderbilt University School of Medicine Basic Sciences have found that cells in the pancreas form new cell types to mitigate injury, but are then susceptible to cancerous mutations. Read more...
The Future of Pancreatic Cancer Treatment: It’s Personal A decade ago, the survival rate for pancreatic cancer hovered around five percent. Today, the five-year survival rate is 10 percent. “We’ve moved into the double-digits, but there is clearly an urgent need to find better therapies to treat cancer of the
New Immunotherapy Approach Wiped Out Tumors in Two Patients with Advanced Lung Cancer, Study Reports
New Immunotherapy Approach Wiped Out Tumors in Two Patients with Advanced Lung Cancer, Study Reports Drugs called immune checkpoint inhibitors have transformed treatment of many types of tumors, but metastatic lung cancer has proven more challenging: While these medications have significantly extended survival for some patients, most still do not
Acoustically Triggered Nanorobotics Hold Promise for Cancer Treatment Many incredible cancer-fighting drugs and treatments have been developed in the past few decades, and on paper, they seem like they hold the cure. Because of the way the human body is designed, however, the drugs have a difficult time actually reaching